Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: majaman1978 who wrote (26955)	12/12/1998 11:27:00 AM
From: JEB	Read Replies (1) \| Respond to of 119973

Yes, I noticed Biogen and Genentech are trickling down into oblivion. I guess I should dump my shares of Biogen (BGEN) before they become wallpaper. I learned my lesson many, many years ago. Pick the right company.

To: majaman1978 who wrote (26955)	12/12/1998 3:58:00 PM
From: hoffy	Read Replies (1) \| Respond to of 119973

I agree but there are some biotechs that make it and I really feel that gene therapy will be an area where a lot of the new cures for many diseases comes from. CEGE is the leader in this technology and will be the clear winner in the future. This is in my opinion after researching what these companies have been doing, the patents they hold, the stages they are in, in their research etc. Good luck with ASTM, I have no position in it but will watch it. I picked CEGE to be the winner in this field so I will stay with them until I see reason to change that opinion. In a few years they could very well be the next big biotech story with the hottest new technology.